307
Views
27
CrossRef citations to date
0
Altmetric
Review

Frailty assessment in older adults with chronic obstructive respiratory diseases

&
Pages 1513-1524 | Published online: 29 Aug 2018

Abstract

The number of patients with chronic obstructive pulmonary disease (COPD) has been rising with continued exposure to environmental risk factors and aging of populations around the world. Frailty is a geriatric syndrome with a decline in physiological reserve and often coexists with chronic diseases such as COPD. Frailty is an independent risk factor for the development and progression of COPD, and COPD can lead to frailty; treating one might improve the other. Thus, there is an increasing interest in the assessment of frailty in patients with COPD. Furthermore, early identification and assessment of frailty in patients with COPD may affect the choice of intervention and improve its effectiveness. Based on the current literature, the intent of this review was to summarize and discuss frailty assessment tools used for COPD patients and the relevant clinical practices for predicting outcomes. We ascertain that using suitable frailty assessment tools could facilitate physicians to screen and stratify physically frail patients with COPD. Screening appropriately targeted population can achieve better intervention outcomes and pulmonary rehabilitation among frail COPD patients.

Introduction

As the world’s population ages, frailty is becoming more and more important in health and medical care. Frailty can be regarded as a common sequela of aging; however, it is different from aging and disability as up to 75% of patients >85 years of age are not frail.Citation1 Frailty is a geriatric syndrome that has been defined as a state of increased vulnerability from age-associated decline in reserve and function, resulting in reduced ability to cope with daily or acute stressors.Citation2,Citation3 Once stressors strike, frail older adults are more prone to disastrous health outcomes, even disability and death.Citation4Citation7 Frailty has been shown to be highly correlated with the quality of life, hospital admissions, and mortality,Citation8Citation11 as well as untoward consequences of other geriatric syndromes, such as falls, delirium, depression, cognitive impairment, and incontinence.Citation12 It should be noted that frailty, in our belief, definitely calls for a practical and a more holistic viewpoint in the care of elderly patients.Citation13 However, the symptoms of frailty will go unnoticed by physicians in primary care and clinics, unless frailty is actively identified. The authors are happy to see that an international consensus group has suggested that all persons >70 years of age should be screened for frailty.Citation14

Frailty often coexists with chronic diseases. Recent studies have suggested a higher prevalence of frailty in people with chronic conditions.Citation15,Citation16 Despite the fact that more than half of the older people with chronic diseases such as heart failureCitation17 and chronic obstructive pulmonary disease (COPD) might be frail,Citation6 most physicians often focus on specific diseases, such as diabetes, heart failure, and COPD, instead of the early diagnosis and intervention of frailty, which might lead to the occurrence of unexpected adverse outcomes in older adults. Once frailty develops, a new physiological stressor (eg, acute exacerbation of COPD [AE-COPD] or critical illness) can overwhelm the already diminished physiologic reserve, resulting in disability, severe morbidity, or even death.Citation18 Therefore, the American Geriatrics Society (AGS), the National Institute on Aging (NIA), and the Alliance for Academic Internal Medicine held a joint conference in 2015 with the purpose to advance the field of frailty research among relevant medical specialties.Citation19

COPD is a common, preventable, treatable disease that is characterized by persistent respiratory symptoms and airflow limitations. COPD is usually progressive and associated with an enhanced chronic inflammatory response in the airways and the lung to noxious particles or gases.Citation20 COPD is projected to become the third leading cause of death by 2020. More than 3 million people died of COPD in 2012, accounting for 6% of all deaths globally.Citation21 The COPD burden is projected to increase in the ensuing decades because of continuing exposure to COPD risk factors and the aging of the population.Citation22 In the elderly, the diagnosis of COPD is often delayed due to atypical symptoms; the frequency of acute exacerbations is higher than that in the younger people, and respiratory failure is more likely to occur among the elderly.

To date, frailty has been used to assess many chronic diseases, such as cardiovascular diseases, chronic kidney disease, and obesity.Citation23Citation25 Increasing attention is being given to frailty assessment in patients with chronic lung diseases.Citation26 Indeed, several recent studies have shown a significant increase in the incidence of frailty in chronic lung disease.Citation27,Citation28 The prognostic utility of frailty in patients with chronic respiratory diseases for mortality and hospitalization has been validated,Citation29Citation31 and physical frailty has been shown to be amenable to treatment with pulmonary rehabilitation.Citation32 However, frailty assessment in older adults with COPD is still controversial. In this review, we summarized assessment tools for frailty in patients with COPD, briefly presented the underlying pathological pathways and potential biomarkers for frailty and COPD, and discussed the strategies for prevention and intervention in frail older adults with COPD.

Prevalence of frailty in patients with COPD

Depending on the assessment methods and heterogeneity of the population, the prevalence of frailty varies greatly.Citation33,Citation34 The general trend of frailty prevalence increases with age, and the prevalence in women is higher than that in men. Frailty is estimated to affect 10.7% of community-dwelling adults >65 years of age, 15.7% of adults 80–84 years of age, and 26.1% of adults >85 years of age.Citation35 In frail females, the probability of falling is threefold greater than those who are not frail.Citation36

The prevalence of frailty in patients with COPD has been reported to range from 6.6% to 75.5%, depending on the populations studied the frailty screening tools used;Citation6,Citation28,Citation29,Citation32 frailty has been shown to correlate with the severity of COPD.Citation4,Citation29 A recent meta-analysisCitation37 showed that patients with COPD have a twofold greater risk for frailty than patients without COPD. Specifically, the pooled prevalence of prefrailty with COPD was 56% (95% CI=52%–60%; I2=80.8%) and that of frailty with COPD was 20% (95% CI=15%–24%; I2=94.4%).Citation37

Common pathological pathways and biomarkers for frailty and COPD

COPD and frailty share some important common risk factors. Cumulative exposure to tobacco, respiratory infections, occupational dust, and air pollution and advanced age can lead to respiratory impairment. In turn, respiratory impairment can increase the risk for adverse outcomes. In addition to respiratory tract symptoms, extrapulmonary manifestations in COPD patients are very similar to the symptoms of frailty, such as fatigue, weight loss, reduced physical activities, muscle weakness, and osteoporosis. Once frailty develops, the AE-COPD, as a new physiological stressor, can result in progressively worsening conditions ranging from disability and morbidity to death. The frequent coexistence of COPD and frailty seems to suggest a common underlying pathophysiological mechanism (see later).Citation29

Inflammation

Inflammation is known to play an important role in the development of COPD. Moreover, chronic inflammation is considered to be one of the primary pathobiological changes driving frailty.Citation38 A number of studies have focused on inflammation and frailty.Citation39Citation43 Frail adults have increased serum levels of the proinflammatory cytokine, interleukin-6, compared with non-frail adults,Citation44 which has been consistently found to be associated with frailty in both cross-sectionalCitation45 and prospective studies.Citation39Citation43 The Cardiovascular Health Study (CHS) reported that frail participants had an increased level of C-reactive protein (CRP),Citation42 and tumor necrosis factor-alpha and receptors were shown to be associated with frailty.Citation40,Citation46,Citation47 Patients with COPD showed signs of chronic inflammation; higher levels of systemic proinflammation biomarkers are associated with poorer physical functioning, more exacerbations, and death.Citation48Citation50

Endocrine dysfunction

Endocrine dysfunction, especially the hypothalamic–pituitary axis, which controls metabolism and energy use through the signaling actions of a series of homoeostatic hormones,Citation51 has also been found to be associated with frailty. Frail adults have lower levels of IGF-1,Citation52Citation56 sex hormones,Citation57,Citation58 25-hydroxy vitamin D,Citation59Citation62 and dehydroepiandrosterone (DHEA).Citation63,Citation64 COPD affects the function of the endocrine system through hypoxemia, hypercapnia, systemic inflammation, and gluco-corticoid administration. In turn, altered endocrine function may further contribute to the already aggravated clinical manifestations of COPD.Citation65

Sarcopenia

Clinically, frailty may copresent with sarcopenia. Sarcopenia, defined as an abnormally low lean muscle mass combined with low muscle strength or function,Citation66 is a fundamentally important cause of frailty.Citation67 The mechanisms underlying sarcopenia include protein and micronutrient deficiencies, chronic inflammation, endocrine dysregulation, and disuse atrophy.Citation68 Several studies found that sarcopenia is more common in patients with COPD than in matched healthy controls.Citation69Citation71 In addition, adults with COPD exhibit skeletal muscle dysfunction at the biochemical, cellular, and structural levels.Citation72,Citation73 Finally, as the severity of COPD and the concomitant dyspnea worsens, patients can experience decrease in muscle strength, impaired mobility, sarcopenia, and ultimately, frailty.

Assessment tools for frailty used in COPD and clinical practice

Increasing evidence supports the use of frailty assessment to predict clinical outcomes in patients with chronic lung diseases, especially with COPD (). Screening for frailty can be used as a prognostic tool to help with treatment decision-making and risk stratification; this will have importance in differentiating patients who will benefit from the treatment from those who may obtain no benefit or even experience harmful consequences from interventions and pulmonary rehabilitation.Citation32,Citation74

Table 1 Summary of the selected studies on frailty and COPD in different populations

Fried frailty phenotype (FFP)

Most studies involving the interactions between COPD and frailty were assessed by the FFP. The FFP,Citation75 often known as the CHS index, has five core domains, including slowness (slow gait speed), weakness (low grip strength), low physical activity (Minnesota Leisure Time Activity), exhaustion (Center for Epidemiologic Studies-Depression [CES-D] questionnaire), and weight loss (self-reported weight loss of 4.5 kg or recorded weight loss of 5% in the last year). Patients with 3–5, 1–2, and 0 factors are classified as frail, pre-frail, and robust, respectively. The FFP is the most frequently cited frailty toolCitation76 and has been used to predict mortality and adverse clinical outcomes in large cohorts of community-dwelling elders.Citation77,Citation78

In the following, we describe several studies to demonstrate the relevance and impact of FFP frailty assessment; these studies were each carried out with a different participant group, ie, community-based, stable COPD outpatients, and advanced COPD in hospital and immunodeficient patient group, respectively.

Community-based population

Vaz Fragoso et alCitation31 used the CHS data for their community-based, large population study and evaluated the relationship between a modified version of the FFP and respiratory impairment in 3,578 participants; respiratory impairment included airflow limitation or restriction as measured by spirometry using contemporary protocols of the American Thoracic Society. Participants completed a battery of assessments at baseline and 4 years thereafter and underwent up to 12 years of vital status follow-up evaluations. After adjusting for relevant covariates, pre-frail and frail participants were found to have a 42% higher likelihood of developing respiratory impairment than participants who were non-frail. Conversely, participants with respiratory impairment at baseline had a 58% higher likelihood of developing pre-frailty or frailty than participants without respiratory impairment at baseline. The impact of baseline respiratory impairment and frailty status on mortality appeared to be synergistic as well. Compared with non-frail subjects with normal respiratory function, frail subjects with respiratory impairment had a nearly fourfold higher risk for death. The risk for death was at least twofold higher for frail subjects with respiratory impairment than that for non-frail subjects with respiratory impairment or frail subjects without respiratory impairment. Another population-based study evaluated 2,142 community-dwelling older adults (402 with COPD and 1,740 without COPD) who had an FFP assessment and underwent spirometry.Citation29 The participants with COPD were more than twice as likely to be frail as those without COPD; this association was stronger with COPD of increased severity according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria. During an average follow-up of 805 days, frail participants with COPD had a nearly threefold higher mortality rate than non-frail participants without COPD. Notably, frailty status was a stronger determinant of mortality than the FEV1% or comorbidity.

Stable COPD outpatients

FFP was also used for assessing frailty in stable COPD outpatients. Mittal et alCitation28 reported that frailty is relatively common in ambulatory patients with chronic lung diseases recruited from clinics and a rehabilitation center. Patients with COPD accounted for 56% of the total patients. Frail patients had higher self-reported hospitalizations and falls and lower gait speeds. Based on FFP, self-reported exhaustion (90.5%) and slow gait speed (76.2%) were the most common frailty criteria. The simple screening tool, gait speed, can be used to screen frail patients with a high sensitivity but a low specificity. To evaluate the rehabilitation outcomes of stable COPD outpatients, a studyCitation32 showed that frail patients with stable COPD appropriate for a pulmonary rehabilitation referral had more difficulty engaging in pulmonary rehabilitation. Frailty is both a strong and an independent risk factor for failure to complete pulmonary rehabilitation than smoking status, breathlessness, or low mood. Although frail patients with COPD were more unlikely to complete rehabilitation, the frailty phenotype was reversed for stable COPD patients who did complete pulmonary rehabilitation. In addition, they appeared to have more favorable rehabilitation outcomes, including physical, psychological, and global health improvement.Citation32 Therefore, proactively screening frail stable COPD patients and researching a better means to support frail patients through rehabilitation will direct clinicians to make a greater effort to identify suitable patients for pulmonary rehabilitation referral who are more likely to benefit from the intervention.

Clinically advanced and critical patients

For frailty assessment in patients with advanced and critical lung disease, the FFP has limitations. Baldwin et alCitation79 showed that the Minnesota Leisure Time Physical Activity Questionnaire (MLTA) has a significant floor effect in patients with advanced lung disease and in critical care survivors. In this study,Citation79 they measured frailty physical activity using the Duke Activity Scale Index (DASI) and the MLTA in two cohorts of patients (advanced lung disease patients awaiting lung transplantation and survivors of acute respiratory failure). The resultsCitation79 showed that the DASI performed better and had a less pronounced floor effect than MLTA in this patient population and was more predictive of frailty outcome. The DASI queries activities more relevant to adults with advanced lung disease or to survivors of critical illness, and thus can minimize misclassification of frailty attributable to low activity and can better discriminate between different levels of activities relevant to the fields of pulmonary and critical care medicine.Citation79 The FFP is based on the experience of suburban community-dwelling older adults who had fewer activity limitations than adults with advanced lung disease or older survivors of acute respiratory failure.Citation79 Because of this fundamental context, it is perhaps not surprising to see that FFP has proven limited utility for the care of this category of patients.

Immunodeficient population

An adapted FFP (Multicenter AIDS Cohort Study [MACS]-based survey with four domains [physical shrinking, exhaustion, slowness, and decreased physical activity]) was used to measure frailty in an immunodeficient population drawn from the Veterans Aging Cohort Study (VACS) by comparing HIV-infected individuals with HIV-uninfected individuals. COPD was an independent risk factor for frailty in HIV-infected patients;Citation80 it was diagnosed in 4% of 3,538 HIV-infected participants and 5% of 3,606 HIV-uninfected participants. Using the adapted frailty-related phenotype (aFRP) assessment tool, 59% of HIV-infected patients and 58% of HIV-uninfected patients with COPD met the criteria for pre-frailty vs 34% of HIV-infected patients and HIV-uninfected patients without COPD. The association between COPD and the physical limitation scale was stronger in HIV-infected participants compared with HIV-uninfected participants.Citation81

Overall, FFP is a practical assessment tool for frailty patients with COPD and has been widely adopted by the research and clinical communities.

FRAIL scale

FRAIL, proposed by the International Association of Nutrition and Aging,Citation82 comprises five components (fatigue, resistance, ambulation, illness, and loss of weight). FRAIL is administered in the format of a simple, self-report questionnaire based on the phenotype model. Patients reporting 3–5, 1–2, and 0 factors are classified as frail, pre-frail, and robust, respectively. In addition, FRAIL is an independent risk factor for predicting mortality and adverse outcomes in specific populations.Citation83Citation85

Using the FRAIL scale, a cross-sectional study in Thailand reported that the prevalence of frailty in COPD patients was 6.6%. Each component of the FRAIL scale showed a greater rate in frail patients than that in non-frail patients, and fatigue was the main factor of frailty in these populations. Interestingly, this study was a sub-study of “Sarcopenia in COPD”, which found that sarcopenia was indeed associated with frailty. Therefore, in theory, frail COPD patients might benefit from the prevention of sarcopenia.Citation86 Although the FRAIL scale is a simple, self-report tool to measure frailty based on the phenotype, there have not been any validated studies involving hospitalized participants.

Frailty Index (FI) and the FI derived from a Comprehensive Geriatric Assessment (FI-CGA)

The Rockwood Accumulative Deficits Index,Citation87 also referred to as the FI, was developed on the basis of the Canadian Study of Health and Aging (CSHA) as a multidimensional measure of frailty. The FI expresses the theory of gradation of frailty with progressive accumulation of deficits, each of which has an equal weight in mathematical modeling;Citation88 FI involves the accumulation of 20–70 age-related indicators of health, including comorbidities, symptoms, diseases, disabilities, or any deficiency in health.Citation89 The deficit model enables the use of clinical data collected from medical records for frailty assessment, thus making it possible to identify frail elderly people who will achieve improved outcomes from interventions.Citation90 Despite this, the calculation of FI is time consuming, and its mathematical nature renders the FI unpopular in clinics.Citation91 CGA is the global standard clinical assessment for older people. FI-CGA is a simple FI using data from a CGA. The FI-CGA was calculated by dividing the total number of CGA deficits.

In a community-based cross-sectional analysis, all participants, including 520 patients diagnosed with COPD and 150 comparators, completed a modified version of the CGA questionnaire. Using FI-CGA assessment and the age-adjusted cutoff for frailty from the Survey of Health, Aging, and Retirement in Europe, the study showed that the prevalence of frailty was 28% in COPD patients and 0% in comparators. Frail participants also had poorer lung function and physical activity (handgrip and 6-minute walking distance), greater inflammation (fibrinogen and high-sensitivity CRP) and more exacerbations, symptoms, and a poorer health-related quality of life than comparators.Citation92

Kihon Checklist (KCL)

KCL is a validated frailty measurement tool consisting of 25 yes/no questions proposed by the Ministry of Health, Labor, and Welfare of Japan.Citation93 The 25 self-report questions are grouped into seven categories including instrumental (three scores) and social activities of daily living (four scores), physical functions (five scores), nutritional status (two scores), oral function (three scores), cognitive functions (three scores), and mood (five scores).Citation94 The KCL showed predictive utility for the incidence of dependency and mortality in community-dwelling older people.Citation95

Using the KCL frailty assessment tool, Kusunose et alCitation96 showed a significant association between frailty status and St George’s Respiratory Questionnaire in patients with stable COPD. Frailty appeared to have developed via an independent mechanism except for age-related deterioration in patients with COPD. Frailty assessment was recommended to be included as a part of multidimensional measurements of COPD.Citation96 However, similar to FRAIL scale, further validation studies of the KCL in hospitalized COPD patients need to be undertaken.

Edmonton Frail Scale (EFS) and Reported Edmonton Frail Scale (REFS)

The EFS, extracted from CGAs, is a valid and reliable screening tool for the identification of frailty. The EFS has a maximum score of 17 and consists of the following domains: cognition, general health status, functional independence, social support, medication use, mood, continence, nutrition, and functional performance.Citation97 The REFS adapted the domain “get up and go” to a report of physical function, which was developed in acute care. The reported physical function increased the functional score, and therefore, the component scores are summed from items 1 to 18. The severity of frailty is classified as follows: “not frail (0–5), apparently vulnerable (6–7), mildly frail (8–9), moderately frail (10–11), and severe frailty (12–18)”.Citation98

A prospective study was designed to observe COPD patients hospitalized with exacerbations in acute medical wards and during follow-up within 90 days after hospital discharge. Frailty of patients with AE-COPD was assessed within 48–96 hours of hospital admission using the REFS. Frailty was categorized into the following four predefined categories: not frail or vulnerable (44.7%), mild frailty (19.4%), moderate frailty (17.5%), and severe frailty (18.4%). The 90-day readmission rates were found to increase with the severity of frailty. Patients with “severe frailty” were approximately fivefold more likely to have readmission than those with “non-frail” status. In addition, frailty was an independent predictor of readmission within 90 days in patients with AE-COPD.Citation99

Frailty Staging System (FSS)

The FSS, as an index of functional impairment severity, was modified from a previous screening method for functional disability in elderly people.Citation100 The FSS covers the following seven core categories: disability, mobility, cognitive function, visual function, hearing function, urinary continence, and social support.Citation101

The FSS frailty assessment tool was used in a study involving 489 patients with COPD with a follow-up period of 12 years.Citation102 The severity of frailty was classified according to the number of frail domains: mild, one domain; moderate, two or three domains; and severe, four or more domains. Mortality was increased from 48.1% in patients without COPD to 60.7% in patients with COPD. In patients with increasing severity of frailty, mortality increased from 54.3% in patients without COPD to 97.0% in patients with COPD. Therefore, clinical frailty may be considered as a prognostic factor when identifying COPD patients at high risk for mortality.Citation102

Tilburg Frailty Indicator (TFI)

The TFI has been proven to have good validity and reliability for community-dwelling older people.Citation103 The TFI is an easy-to-administer questionnaire based on an integral conceptual model of frailty containing 15 self-report categories (eleven “yes/no” questions and four “sometimes” questions). The TFI refers to the following three categories of frailty: physical frailty (health, unexplained weight loss, difficulty in walking, balance, poor hearing, vision, lack of strength in the hands, and tiredness), psychological frailty (problems with memory, feeling down, anxiety, and inability to cope with problems), and social frailty (living alone, lack of social relations, and social support). A score >5 is the best cutoff point indicative of frailty.Citation104,Citation105

Nine-item criteria modified from the TFI were used in a community-based study that included 211 participants with COPD and a history of smoking from the National Health and Nutrition Evaluation Survey (NHANES) dataset (2003–2006) of 20,470 participants.Citation6 Of the 211 participants, 57.8% were diagnosed with frailty among the participants with COPD. The study showed that patients with COPD who had shortness of breath were more likely to be frail than patients who did not have COPD. Frail people with COPD were associated with impairments in activities of daily living/instrumental activities of daily living.

Uchmanowicz et al used the TFI to evaluate the association between the level of acceptance of illness and frailty in 102 COPD patients hospitalized with an exacerbation. Frailty was diagnosed in >75% of the COPD patient group. Elderly patients with severe COPD were more prone to frailty and had lower levels of disease acceptance than other chronic diseases. Patients with a higher level of frailty in physical and social domains correlated with a lower level of acceptance of illness.Citation4

Summary

Frailty evaluation in patients with COPD is a feasible prognostic utility for mortality and hospitalization. Physical frailty screening may help identify those patients who will be more likely to benefit from available interventions for other illnesses as shown in the study with frail COPD patients.Citation31

The FFP is the most widely used frailty assessment tool and has been validated in many studies. However, in the case of severe COPD exacerbations, it is still very difficult to predict intensive care unit (ICU) outcomes. Identifying patients who are likely or indeed unlikely to benefit from admission to ICU wards would greatly improve the quality of care provided to these patients, enable patients to make better advance directives and allow health care workers to offer palliative care in a timely manner to patients with a high risk for severe morbidity and mortality. As a first step, it is a reasonable strategy to consider using various tools, in their original or modified form, or with different cutoff values to evaluate the effect of frailty on outcomes from intervention delivered to the specific populations.

Intervention

Frailty is an independent risk factor for exacerbations and progression of COPD, and patients with COPD are also more prone to frailty. Although frailty and COPD affect each other, both frailty and respiratory impairment can be modulated and treated. When one is treated and/or prevented, the other may be improved. Therefore, a more thorough understanding of the relationship between frailty and COPD can help clinicians better prevent and intervene in patients with these two conditions and may reduce the occurrence of poor outcomes.Citation31

Muscle wasting, weakness, and malnutrition are common in patients with lung disease and could be responsive to physical exercise training and nutrition optimization. This underscores the importance of rehabilitation. Moreover, pulmonary rehabilitation has been shown to reverse frail patients with COPD who responded well to treatment.Citation32 Similarly, many factors related to frailty can also be improved through prevention and supportive treatment, such as suitable exercise and nutritional support. Positive treatment effects among these frailty constructs may partially explain why pulmonary rehabilitation improves exercise capacity, disability, and health-related quality of life and reduces hospitalizations and mortality.Citation106,Citation107 Recent work in older populations has shown that frailty may be reversible through targeted exercise and nutritional interventions.Citation108Citation110 It has been postulated that nutritional interventions may be suitable for frail patients with nutritional deficiency and weight loss; however, the evidence for this has been scarce. A systematic review showed that sustained nutritional supplementation had no significant effect on pulmonary function, respiratory muscle strength, and functional exercise capacity in patients with stable COPD.Citation111 Individual nutrition supplementation may not be able to reverse the decline in muscle strength and function if the intervention is given too late.Citation112,Citation113 Further research is needed to determine what constitutes effective nutrition interventions.Citation114

Some studies have reported the effects of various pharmacotherapies targeting the biological frailty pathway, including angiotensin-converting enzyme inhibitors,Citation115 DHEA, testosterone, recombinant human growth hormone,Citation116 and vitamin D.Citation117 There are no sufficient data to recommend any of these agents for routine use.

There is increasing evidence to support the notion that a comprehensive assessment can help to mitigate the risk factors associated with frailty.Citation118,Citation119 Frailty and pre-frailty are common in patients with COPD; however, using multidisciplinary intervention, patients with frailty can be reversed, especially at the pre-frailty stage.Citation120 Therefore, it is critical to diagnose frailty at an early stage. Furthermore, early intervention through comprehensive assessments, referral exercise, and nutritional interventions would prevent and delay the progression of frailty.

Conclusion

Frailty and COPD have a strong association in aged population. Treating the frailty syndrome will likely reduce risk for poor COPD outcomes. Early recognition of frailty is important in patients with COPD, as early and effective interventions can prevent or delay functional deterioration, institutionalization, disability, and death. Assessment of frail COPD patients can provide better stratification of risks and individual management and improve patient outcomes. There remains controversy in the literature regarding the best frailty assessment tool in older adults with COPD. Some frailty assessment tools are suitable for screening the health status of community populations, whereas others are suitable for assessing outpatients or emergency patients. Further research in this field is warranted, and it should target specific patient groups in order to establish more effective assessment tools, which would improve the effectiveness of screening and identifying patients at different stages of frailty, thus allowing health care workers to apply individual-specific treatment regimen.

Acknowledgments

This work was supported by a grant from the National Natural Science Foundation of China (No 81201832) and the Natural Science Foundation of Liaoning Province (No 201602846).

Disclosure

The authors report no conflicts of interest in this work.

References

  • SongXMitnitskiARockwoodKPrevalenceRKPrevalence and 10-year outcomes of frailty in older adults in relation to deficit accumulationJ Am Geriatr Soc201058468168720345864
  • XueQ-LThe frailty syndrome: definition and natural historyClin Geriatr Med201127111521093718
  • BergmanHFerrucciLGuralnikJFrailty: an emerging research and clinical paradigm – issues and controversiesJ Gerontol A Biol Sci Med Sci200762773173717634320
  • UchmanowiczIJankowska-PolańskaBChabowskiMUchmanowiczBFalAMThe influence of frailty syndrome on acceptance of illness in elderly patients with chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2016112401240727729781
  • Díaz de León GonzálezEGutiérrez HermosilloHMartinez BeltranJAValidation of the FRAIL scale in Mexican elderly: results from the Mexican Health and Aging StudyAging Clin Exp Res201628590190826646253
  • ParkSKRichardsonCRHollemanRGLarsonJLFrailty in people with COPD, using the National Health and Nutrition Evaluation Survey dataset (2003–2006)Heart & Lung: The Journal of Acute and Critical Care201342316317023535142
  • WooJYuRWongMYeungFWongMLumCFrailty screening in the community using the FRAIL scaleJ Am Med Dir Assoc201516541241925732832
  • MaselMCGrahamJEReistetterTAMarkidesKSOttenbacherKJFrailty and health related quality of life in older Mexican AmericansHealth Qual Life Outcomes2009717019627598
  • MitnitskiABGrahamJEMogilnerAJRockwoodKFrailty, fitness and late-life mortality in relation to chronological and biological ageBMC Geriatr200221111897015
  • CarlsonJEZocchiKABettencourtDMMeasuring frailty in the hospitalized elderly: concept of functional homeostasisAm J Phys Med Rehabil19987732522579635561
  • MaLZhangLTangZUse of the frailty index in evaluating the prognosis of older people in Beijing: a cohort study with an 8-year follow-upArch Gerontol Geriatr20166417217726778493
  • JoostenEDemuynckMDetroyerEMilisenKPrevalence of frailty and its ability to predict in hospital delirium, falls, and 6-month mortality in hospitalized older patientsBMC Geriatr2014141124393272
  • CleggAYoungJIliffeSRikkertMORockwoodKFrailty in elderly peopleLancet2013381986875276223395245
  • MorleyJEVellasBvan KanGAAbellan van KanGFrailty consensus: a call to actionJ Am Med Dir Assoc201314639239723764209
  • VaughanLGoveasJCorbinADepression and frailty in later life: a systematic reviewClin Interv Aging2015101947195826719681
  • MaLTangZZhangLSunFLiYChanPPrevalence of frailty and associated factors in the community-dwelling population of ChinaJ Am Geriatr Soc201866355956429168883
  • McnallanSMSinghMChamberlainAMFrailty and healthcare utilization among patients with heart failure in the communityJACC Heart Fail20131213514123956958
  • SingerJPLedererDJBaldwinMRFrailty in pulmonary and critical care medicineAnn Am Thorac Soc20161381394140427104873
  • WalstonJRobinsonTNZiemanSIntegrating frailty research into the medical specialties – Report from a U13 conferenceJ Am Geriatr Soc201765102134213928422280
  • VogelmeierCFCrinerGJMartínezFJGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive SummaryArch Bronconeumol201753312814928274597
  • GifcolDGlobal Strategy for the Diagnosis, Management and Prevention of COPDGlobal Initiative for Chronic Obstructive Lung Disease2018 http://www.goldcopd.org
  • MathersCDLoncarDProjections of global mortality and burden of disease from 2002 to 2030PLoS Med2006311e44217132052
  • UchmanowiczILisiakMWontorRFrailty syndrome in cardiovascular disease: clinical significance and research toolsEur J Cardiovasc Nurs201514430330925595359
  • BlaumCSXueQLMichelonESembaRDFriedLPThe association between obesity and the frailty syndrome in older women: the Women’s Health and Aging StudiesJ Am Geriatr Soc200553692793415935013
  • BohmCStorsleyLTangriNThe assessment of frailty in older people with chronic kidney diseaseCurr Opin Nephrol Hypertens201524649850426447796
  • LuckhardtTThannickalVJMeasures of frailty in chronic lung diseasesAnn Am Thorac Soc20171481266126728763264
  • MilneKMKwanJMGulerSFrailty is common and strongly associated with dyspnoea severity in fibrotic interstitial lung diseaseRespirology201722472873427860036
  • MittalNRajRIslamEANugentKThe frequency of frailty in ambulatory patients with chronic lung diseasesJ Prim Care Community Health201671101526333537
  • LahousseLZiereGVerlindenVJARisk of frailty in elderly with COPD: a population-based studyJ Gerontol A Biol Sci Med Sci201671568969526355016
  • SingerJPDiamondJMGriesCJFrailty phenotypes, disability, and outcomes in adult candidates for lung transplantationAm J Respir Crit Care Med2015192111325133426258797
  • Vaz FragosoCAEnrightPLMcavayGvan NessPHGillTMFrailty and respiratory impairment in older personsAm J Med20121251798622195532
  • MaddocksMKonSSCCanavanJLPhysical frailty and pulmonary rehabilitation in COPD: a prospective cohort studyThorax2016711198899527293209
  • ShamliyanTTalleyKMCRamakrishnanRKaneRLAssociation of frailty with survival: a systematic literature reviewAgeing Res Rev201312271973622426304
  • van IerselMBRikkertMGFrailty criteria give heterogeneous results when applied in clinical practiceJ Am Geriatr Soc200654472872916686901
  • CollardRMBoterHSchoeversRAOude VoshaarRCPrevalence of frailty in community-dwelling older persons: a systematic reviewJ Am Geriatr Soc20126081487149222881367
  • TomSEAdachiJDAndersonFAFrailty and fracture, disability, and falls: a multiple country study from the global longitudinal study of osteoporosis in womenJ Am Geriatr Soc201361332733423351064
  • MarengoniAVetranoDLManes-GravinaEBernabeiROnderGPalmerKThe relationship between COPD and frailty: a systematic review and meta-analysis of observational studiesChest20181541214029477493
  • ChenXMaoGLengSXFrailty syndrome: an overviewClin Interv Aging2014943344124672230
  • HubbardREO’MahonyMSCalverBLWoodhouseKWNutrition, inflammation, and leptin levels in aging and frailtyJ Am Geriatr Soc200856227928418179487
  • HubbardREO’MahonyMSSavvaGMCalverBLWoodhouseKWInflammation and frailty measures in older peopleJ Cell Mol Med2009139b3103310919438806
  • CesariMPenninxBWJHPahorMInflammatory markers and physical performance in older persons: the InCHIANTI studyJ Gerontol A Biol Sci Med Sci2004593M242M248
  • WalstonJMcburnieMANewmanAFrailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health StudyArch Intern Med2002162202333234112418947
  • BarzilayJIBlaumCMooreTInsulin resistance and inflammation as precursors of frailty: the Cardiovascular Health StudyArch Intern Med2007167763564117420420
  • LengSChavesPKoenigKWalstonJSerum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot studyJ Am Geriatr Soc20025071268127112133023
  • MatheïCVaesBWallemacqPDegryseJAssociations between cytomegalovirus infection and functional impairment and frailty in the BELFRAIL cohortJ Am Geriatr Soc201159122201220822092044
  • ServiddioGRomanoADGrecoAFrailty syndrome is associated with altered circulating redox balance and increased markers of oxidative stressInt J Immunopathol Pharmacol200922381982719822098
  • VaradhanRYaoWMatteiniASimple biologically informed inflammatory index of two serum cytokines predicts 10 year all-cause mortality in older adultsJ Gerontol A Biol Sci Med Sci201469A2165173
  • AgustíAEdwardsLDRennardSIPersistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotypePLoS One201275e3748322624038
  • KaradagFKarulABCildagOYilmazMOzcanHBiomarkers of systemic inflammation in stable and exacerbation phases of COPDLung2008186640340918807087
  • ThomsenMIngebrigtsenTSMarottJLInflammatory biomarkers and exacerbations in chronic obstructive pulmonary diseaseJAMA2013309222353236123757083
  • BishopNALuTYanknerBANeural mechanisms of ageing and cognitive declineNature2010464728852953520336135
  • LengSXHungWCappolaARYuQXueQLFriedLPWhite blood cell counts, insulin-like growth factor-1 levels, and frailty in community-dwelling older womenJ Gerontol A Biol Sci Med Sci200964449950219251912
  • CappolaARXueQLFerrucciLGuralnikJMVolpatoSFriedLPInsulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older womenJ Clin Endocrinol Metab20038852019202512727948
  • LengSXCappolaARAndersenRESerum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailtyAging Clin Exp Res200416215315715195991
  • CawthonPMEnsrudKELaughlinGASex hormones and frailty in older men: the osteoporotic fractures in men (MrOS) studyJ Clin Endocrinol Metab200994103806381519737923
  • JosephCKennyAMTaxelPLorenzoJADuqueGKuchelGARole of endocrine-immune dysregulation in osteoporosis, sarcopenia, frailty and fracture riskMol Aspects Med200526318120115811434
  • HydeZFlickerLAlmeidaOPLow free testosterone predicts frailty in older men: the health in men studyJ Clin Endocrinol Metab20109573165317220410223
  • EichholzerMBarbirABasariaSSerum sex steroid hormones and frailty in older American men of the Third National Health and Nutrition Examination Survey (NHANES III)Aging Male201215420821522822787
  • PutsMTEVisserMTwiskJWRDeegDJHLipsPEndocrine and inflammatory markers as predictors of frailtyClin Endocrinol2005634403411
  • TiidusPMLoweDABrownMEstrogen replacement and skeletal muscle: mechanisms and population healthJ Appl Physiol2013115556957823869062
  • TravisonTGNguyenA-HNaganathanVChanges in reproductive hormone concentrations predict the prevalence and progression of the frailty syndrome in older men: the concord health and ageing in men projectJ Clin Endocrinol Metab20119682464247421677041
  • ShardellMHicksGEMillerRRAssociation of low vitamin D levels with the frailty syndrome in men and womenJ Gerontol A Biol Sci Med Sci200964A16975
  • HarenMTMalmstromTKBanksWAPatrickPMillerDKMorleyJELower serum DHEAS levels are associated with a higher degree of physical disability and depressive symptoms in middle-aged to older African American womenMaturitas200757434736017451893
  • VoznesenskyMWalshSDauserDBrindisiJKennyAMThe association between dehydroepiandosterone and frailty in older men and womenAge Ageing200938440140619276095
  • LaghiFAdiguzelNTobinMJEndocrinological derangements in COPDEur Respir J200934497599619797671
  • CesariMLandiFVellasBBernabeiRMarzettiESarcopenia and physical frailty: two sides of the same coinFront Aging Neurosci2014619225120482
  • StudenskiSAPetersKWAlleyDEThe FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimatesJ Gerontol A2014695547558
  • MorleyJESarcopenia in the elderlyFam Pract201229Suppl 1i44i4822399555
  • ScholsAMWJBroekhuizenRWeling-ScheepersCAWoutersEFBody composition and mortality in chronic obstructive pulmonary diseaseAm J Clin Nutr2005821535916002800
  • JonesSEMaddocksMKonSSCSarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitationThorax201570321321825561517
  • GreeningNJHarvey-DunstanTCChaplinEJBedside assessment of quadriceps muscle by ultrasound after admission for acute exacerbations of chronic respiratory diseaseAm J Respir Crit Care Med2015192781081626068143
  • GiffordJRTrinityJDLayecGQuadriceps exercise intolerance in patients with chronic obstructive pulmonary disease: the potential role of altered skeletal muscle mitochondrial respirationJ Appl Physiol2015119888288826272320
  • MaltaisFDecramerMCasaburiRAn official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20141899e15e6224787074
  • IqbalJDenvirMGunnJFrailty assessment in elderly peopleLancet2013381988219851986
  • FriedLPTangenCMWalstonJFrailty in older adults: evidence for a phenotypeJ Gerontol A Biol Sci Med Sci2001563M146M15711253156
  • ButaBJWalstonJDGodinoJGFrailty assessment instruments: Systematic characterization of the uses and contexts of highly-cited instrumentsAgeing Res Rev201626536126674984
  • FriedLPBorhaniNOEnrightPThe cardiovascular health study: Design and rationaleAnn Epidemiol1991132632761669507
  • SourialNWolfsonCBergmanHA correspondence analysis revealed frailty deficits aggregate and are multidimensionalJ Clin Epidemiol201063664765419880286
  • BaldwinMRSingerJPHuangDRefining low physical activity measurement improves frailty assessment in advanced lung disease and survivors of critical illnessAnn Am Thorac Soc20171481270127928398076
  • AlthoffKNJacobsonLPCranstonRDAge, comorbidities, and AIDS predict a frailty phenotype in men who have sex with menJ Gerontol A Biol Sci Med Sci201469218919824127428
  • AkgünKMTateJPOurslerKKAssociation of chronic obstructive pulmonary disease with frailty measurements in HIV-infected and uninfected VeteransAIDS201630142185219327191979
  • MorleyJEMalmstromTKMillerDKA simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African AmericansJ Nutr Health Aging201216760160822836700
  • WooJLeungJMorleyJEComparison of frailty indicators based on clinical phenotype and the multiple deficit approach in predicting mortality and physical limitationJ Am Geriatr Soc20126081478148622861118
  • MalmstromTKMillerDKMorleyJEA Comparison of four frailty modelsJ Am Geriatr Soc201462472172624635726
  • LiYZouYWangSA pilot study of the FRAIL scale on predicting outcomes in Chinese elderly people with type 2 diabetesJ Am Med Dir Assoc2015168714.e7714.e12
  • LimpawattanaPPutraveephongSInthasuwanPBoonsawatWTheerakulpisutDChindaprasirtJFrailty syndrome in ambulatory patients with COPDInt J Chron Obstruct Pulmon Dis2017121193119828458530
  • RockwoodKMitnitskiAFrailty in relation to the accumulation of deficitsJ Gerontol A Biol Sci Med Sci200762772272717634318
  • RockwoodKSongXMacKnightCA global clinical measure of fitness and frailty in elderly peopleCan Med Assoc J2005173548949516129869
  • DentEChapmanIHowellSPiantadosiCVisvanathanRFrailty and functional decline indices predict poor outcomes in hospitalised older peopleAge Ageing201443447748424257468
  • SatakeSAraiHImplications of frailty screening in clinical practiceCurr Opin Clin Nutr Metab Care201720141027763893
  • HubbardREO’MahonyMSWoodhouseKWCharacterising frailty in the clinical setting – a comparison of different approachesAge Ageing200938111511919008304
  • GaleNSAlbarratiAMMunneryMMFrailty: A global measure of the multisystem impact of COPDChron Respir Dis2018 147997231775276
  • FukutomiEOkumiyaKWadaTRelationships between each category of 25-item frailty risk assessment (Kihon Checklist) and newly certified older adults under Long-Term Care Insurance: a 24-month follow-up study in a rural community in JapanGeriatr Gerontol Int201515786487125316532
  • SatakeSSendaKHongY-JValidity of the Kihon Checklist for assessing frailty statusGeriatr Gerontol Int201616670971526171645
  • SatakeSShimokataHSendaKKondoITobaKValidity of total Kihon checklist score for predicting the incidence of 3-year dependency and mortality in a community-dwelling older populationJ Am Med Dir Assoc2017185526e551e552
  • KusunoseMOgaTNakamuraSHasegawaYNishimuraKFrailty and patient-reported outcomes in subjects with chronic obstructive pulmonary disease: are they independent entities?BMJ Open Respir Res201741e000196
  • RolfsonDBMajumdarSRTsuyukiRTTahirARockwoodKValidity and reliability of the Edmonton Frail ScaleAge Ageing200635552652916757522
  • HilmerSNPereraVMitchellSThe assessment of frailty in older people in acute careAustralas J Ageing200928418218819951339
  • Bernabeu-MoraRGarcía-GuillamónGValera-NovellaEGiménez-GiménezLMEscolar-ReinaPMedina-MirapeixFFrailty is a predictive factor of readmission within 90 days of hospitalization for acute exacerbations of chronic obstructive pulmonary disease: a longitudinal studyTher Adv Respir Dis2017111038339228849736
  • LachsMSFeinsteinARCooneyLMA simple procedure for general screening for functional disability in elderly patientsAnn Intern Med199011296997062334082
  • CacciatoreFAbetePMazzellaFFrailty predicts long-term mortality in elderly subjects with chronic heart failureEur J Clin Invest2005351272373016313247
  • GaliziaGCacciatoreFTestaGRole of clinical frailty on long-term mortality of elderly subjects with and without chronic obstructive pulmonary diseaseAging Clin Exp Res201123211812521743290
  • GobbensRJvan AssenMAThe prediction of quality of life by physical, psychological and social components of frailty in community-dwelling older peopleQual Life Res20142382289230024671672
  • GobbensRJvan AssenMALuijkxKGWijnen-SponseleeMTScholsJMThe Tilburg Frailty Indicator: psychometric propertiesJ Am Med Dir Assoc201011534435520511102
  • GobbensRJScholsJMvan AssenMAExploring the efficiency of the Tilburg Frailty Indicator: a reviewClin Interv Aging2017121739175229089748
  • FranssenFMBroekhuizenRJanssenPPWoutersEFScholsAMEffects of whole-body exercise training on body composition and functional capacity in normal-weight patients with COPDChest200412562021202815189917
  • PuhanMAGimeno-SantosECatesCJTroostersTPulmonary rehabilitation following exacerbations of chronic obstructive pulmonary diseaseCochrane Database Syst Rev201612CD00530527930803
  • LathamNKHarrisBABeanJFEffect of a home-based exercise program on functional recovery following rehabilitation after hip fracture: a randomized clinical trialJAMA2014311770070824549550
  • AbizandaPLópezMDGarcíaVPEffects of an oral nutritional supplementation plus physical exercise intervention on the Physical function, nutritional status, and quality of life in frail institutionalized older adults: the ACTIVNES studyJ Am Med Dir Assoc2015165439.e9439.e16
  • FragalaMSDamTTBarberVStrength and function response to clinical interventions of older women categorized by weakness and low lean mass using classifications from the Foundation for the National Institute of Health sarcopenia projectJ Gerontol A Biol Sci Med Sci201570220220925135999
  • FerreiraIMBrooksDLacasseYGoldsteinRSNutritional supplementation in stable chronic obstructive pulmonary diseaseCochrane Database Syst Rev200033CD000998
  • PayetteHBoutierVCoulombeCGray-DonaldKBenefits of nutritional supplementation in free-living, frail, undernourished elderly people: a prospective randomized community trialJ Am Diet Assoc200210281088109512171453
  • WalstonJButaBXueQLFrailty screening and interventions: considerations for clinical practiceClin Geriatr Med2018341253829129215
  • OmidvariAHValiYMurraySMWonderlingDRashidianANutritional screening for improving professional practice for patient outcomes in hospital and primary care settingsCochrane Database Syst Rev201366CD005539
  • OnderGPenninxBWBalkrishnanRRelation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational studyLancet2002359931092693011918911
  • BibasLLeviMBendayanMMullieLFormanDEAfilaloJTherapeutic interventions for frail elderly patients: part I. Published randomized trialsProg Cardiovasc Dis201457213414325216612
  • BauerJMVerlaanSBautmansIEffects of a vitamin D and leucine-enriched whey protein nutritional supplement on measures of sarcopenia in older adults, the PROVIDE study: a randomized, double-blind, placebo-controlled trialJ Am Med Dir Assoc201516974074726170041
  • BeswickADReesKDieppePComplex interventions to improve physical function and maintain independent living in elderly people: a systematic review and meta-analysisLancet2008371961472573518313501
  • EllisGGardnerMTsiachristasAComprehensive geriatric assessment for older adults admitted to hospitalCochrane Database Syst Rev20179CD00621128898390
  • Acosta-BenitoMASevilla-MachucaIUsing prefrailty to detect early disabilityJ Family Community Med201623314014427625579
  • ValenzaMCTorres-SánchezICabrera-MartosIRodríguez-TorresJGonzález-JiménezEMuñoz-CasaubonTPhysical activity as a predictor of absence of frailty in subjects with stable COPD and COPD exacerbationRespir Care201661221221926535000